DIGITAL EDITIONS
Supplements
NP+PA PERSPECTIVES IN DERMATOLOGY
Nuclear Factor Erythroid-2-related Factor 2 Gene Polymorphisms in Vitiligo
J Clin Aesthet Dermatol. 2021;14(6):14–17. by Neveen Emad Sorour, MD; Heba Mohamed Abd El-Kareem, MD; Asmaa Em Ibrahim, MBBCh; and Rehab Mohammed Salem, MD Drs. Sorour and Salem are with the Dermatology Department, Faculty of Medicine, Benha University in Benha, Egypt. Dr. Abd El-Kareem is with the Medical Biochemistry Department, Faculty of Medicine, Benha University
Fibrous Proliferations in Posttransplant Kaposi Sarcoma
J Clin Aesthet Dermatol. 2021;14(6):18–20. by Kevin M. Adams, MD; Philip Milam, MD; Alejandro Gru, MD; and Benjamin H. Kaffenberger, MD Drs. Adams, Milam, and Kaffenberger are with The Ohio State University College of Medicine in Columbus, Ohio. Dr. Gru is with the University of Virginia School of Medicine in Charlottesville, Virginia. FUNDING: No funding
Primary Cutaneous Angiosarcoma of the Scalp with Cranial Invasion in a Patient with Metastatic Breast Cancer
J Clin Aesthet Dermatol. 2021;14(6):22–24. by Selda Yildirim, MD; Yeliz Erdemoglu, MD; Emel Öztürk Durmaz, MD; Gamze Erfan, MD; Deniz Duman, MD; and Emel Dikicioglu Çetin, MD Drs. Yildirim, Erdemoglu, Durmaz, Erfan, and Duman are with the Department of Dermatology at Acibadem Mehmet Ali Aydinlar University School of Medicine in Istanbul, Turkey. Dr. Çetin is
A Rare Case of Trichilemmal Carcinoma: Histology and Management
J Clin Aesthet Dermatol. 2021;14(6):25–30. by Lisa Fronek, DO; Allyson Brahs, DO; Maheera Farsi, DO; and Richard Miller, DO, FAOCD Drs. Fronek, Brahs, and Miller are with HCA Healthcare USF Morsani College of Medicine Largo Medical Center Program in Largo, Florida. Dr. Farsi is with the Department of Mohs Micrographic Surgery at the University of
Heterologous Type I Collagen as an Add-on Therapy to Narrowband Ultraviolet B for the Treatment of Vitiligo: A Pilot Study
J Clin Aesthet Dermatol. 2021;14(6):31–34. by Aikaterini Gkouvi, MD; Electra Nicolaidou, MD, PhD; Andreas Corbo, MD; Gennaro Selvaggi, MD; Antonis Tsimpidakis, MD; Styliani Mastraftsi, MD; and Stamatios Gregoriou, MD, PhD Dr. Gkouvi is in private practice in Thessaloniki, Greece. Drs. Nicolaidou, Tsimpidakis, Mastraftsi, and Gregoriou are with the First Department of Dermatology-Venereology, Faculty of Medicine
ONLINE EXCLUSIVES
Guideline for the Management of Hyaluronic Acid Filler-induced Vascular Occlusion
J Clin Aesthet Dermatol. 2021;14(5):E61–E69. by Gillian Murray, MPharm, PG Dip Clin Pharm, INP; Cormac Convery, MB ChB, MSc, MASLMS; Lee Walker, BDS, MFDS, RCPSG, MJDF, RCS, ENG; and Emma Davies, RN INP Dr. Murray is with Clinical Academic Kings College in London, England. Dr. Convery is with The Ever Clinic in Glasgow, Scotland. Dr. Walker
Customized Treatment Using Microfocused Ultrasound with Visualization for Optimized Patient Outcomes: A Review of Skin-tightening Energy Technologies and a Pan-Asian Adaptation of the Expert Panel’s Gold Standard Consensus
J Clin Aesthet Dermatol. 2021;14(5):E70–E79. by Je-Young Park, MD; Frank Lin, MBBS; Atchima Suwanchinda, MD; Rungsima Wanitphakdeedecha, MD; Jonathan Yu, MD; Ting Song Lim, MD; Jeng Feng Chen, MD; Wilson Ho, MD; Joyce Lim, MBBS; Lanny Juniarty, MD; Yong Seng Kee, MD; Seong Jae Youn, MD; and Sabrina Fabi, MD Dr. Park is with the
Tazarotene 0.045% Lotion for Moderate-to-Severe Acne in Male and Female Participants: A Phase II Post-hoc Analysis
J Clin Aesthet Dermatol. 2021;14(4):E53–E60. by Hilary E. Baldwin, MD; Lawrence J. Green, MD, FAAD; Leon Kircik, MD; Eric Pierre Guenin, PharmD, PhD, MPH; Anya Loncaric Forest, MS; and Radhakrishnan Pillai, PhD Dr. Baldwin is with the Acne Treatment and Research Center in Brooklyn, New York, and Rutgers Robert Wood Johnson Medical Center in New
A Retrospective Cohort Study and Clinical Classification System of Acne Keloidalis Nuchae
J Clin Aesthet Dermatol. 2021;14(4):E61–E67. by Sanusi Umar, MD; Delphine J. Lee, MD, PhD; and Jenna J. Lullo, MD Dr. Umar is with the Department of Medicine at the University of California at Los Angeles in Los Angeles, California; the Division of Dermatology, Harbor-UCLA Medical Center in Torrance, California; and the Dr. U Hair and
Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions
J Clin Aesthet Dermatol. 2021;14(3):E53–E57. by Terry M. Jones, MD, and Iain Stuart, PhD Dr. Jones is with J&S Studies Inc., in College Station, Texas. Dr. Stuart is with VYNE Therapeutics Inc., in Bridgewater, New Jersey. FUNDING: This study was sponsored by Foamix Pharmaceuticals Ltd., a wholly owned subsidiary of VYNE Therapeutics Inc. DISCLOSURES: Dr.
Popular on JCAD.TV
Journal Review: Linda Stein Gold— Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy
Download the JCAD App
DIGITAL EDITIONS
The Journal of Clinical and Aesthetic Dermatology – Providing dermatologists with peer-reviewed, evidence-based information on the latest techniques, and cutting-edge practice management solutions.